The new strengths of Lanoxin will increase the risk for mix-ups among digoxin products

April 2014

The new strengths of Lanoxin will increase the risk for mix-ups among digoxin products.

Lanoxin brand now comes in 0.0625 and 0.1875 mg tablets...to give more dosing flexibility.

But having more options means more chance of errors. Digoxin is a powerful heart med that requires close monitoring. It can lead to irregular heartbeats and even death if a patient receives too much.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Respiratory & Allergy Nebulizer solutions (albuterol, ipratropium, etc) are still causing confusion
Neurology & Pain two new C-II opioids, Zohydro ER (zoh-HYE-droh) and Xartemis XR (ZAR-tem-iss) for treating pain
Heart Failure The new strengths of Lanoxin will increase the risk for mix-ups among digoxin products
Pregnancy whether acetaminophen is risky during pregnancy
Diabetes emphasis on improving care in diabetes patients
Erectile Dysfunction a new drug for erectile dysfunction, Stendra (STEN-druh, avanafil)
Pediatrics dexamethasone for asthma exacerbations
Inhalers new once-daily combo inhaler for COPD, Anoro Ellipta (a-NOR-oh ee-LIP-ta, umeclidinium/vilanterol)
Stroke more focus on preventing strokes in YOUNGER WOMEN
Phosphate Velphoro (vel-FOUR-oh, sucroferric oxyhydroxide) is a new med for patients with kidney disease and high phosphate blood levels
Hypertension when to treat SEVERE hypertension
Controlled Substances how to handle controlled substance Rxs for patients with a "pain contract" or treatment agreement

The new strengths of Lanoxin will increase the risk for mix-ups among digoxin products

Practical advice for a better career, with unlimited access to CE

Table of Contents